Phio Pharmaceuticals Corp. — All Filings
863 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POS EX
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SP 15D2
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-24-131663 | Dec 26, 2024 | — |
| 424B5 | FORM 424B5 | 0001683168-24-008939 | Dec 23, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-008884 | Dec 20, 2024 | Dec 19, 2024 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001683168-24-008867 | Dec 20, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-008833 | Dec 19, 2024 | Dec 18, 2024 |
| 8-K | FORM 8-K | 0001683168-24-008118 | Nov 14, 2024 | — |
| 10-Q | FORM 10-Q FOR SEPT 2024 | 0001683168-24-008120 | Nov 14, 2024 | Sep 30, 2024 |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-24-097266 | Nov 13, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-007713 | Nov 7, 2024 | — |
| 4 | — | 0001683168-24-006377 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-006373 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-006375 | Sep 13, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-006334 | Sep 12, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-006336 | Sep 12, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-006332 | Sep 12, 2024 | Sep 11, 2024 |
| 4 | — | 0001683168-24-005773 | Aug 15, 2024 | Aug 13, 2024 |
| 8-K | CURRENT REPORT | 0001683168-24-005707 | Aug 14, 2024 | — |
| 10-Q | FORM 10-Q FOR JUNE 2024 | 0001683168-24-005706 | Aug 14, 2024 | Jun 30, 2024 |
| 3 | — | 0001683168-24-005394 | Aug 9, 2024 | Aug 1, 2024 |
| 424B3 | FORM 424B3 | 0001683168-24-005259 | Aug 5, 2024 | — |
| EFFECT | — | 9999999995-24-002365 | Aug 1, 2024 | — |
| 8-K | CURRENT REPORT | 0001683168-24-005194 | Aug 1, 2024 | Jul 15, 2024 |
| CORRESP | — | 0001683168-24-005128 | Jul 30, 2024 | — |
| UPLOAD | — | 0000000000-24-008615 | Jul 29, 2024 | — |
| S-1 | REGISTRATION STATEMENT | 0001683168-24-005092 | Jul 26, 2024 | — |
| D | — | 0001123292-24-000200 | Jul 24, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-005049 | Jul 24, 2024 | Jul 19, 2024 |
| 8-K | FORM 8-K | 0001683168-24-004800 | Jul 12, 2024 | Jul 11, 2024 |
| 8-K | FORM 8-K | 0001683168-24-004683 | Jul 5, 2024 | Jul 3, 2024 |
| 8-K | FORM 8-K | 0001683168-24-004619 | Jul 2, 2024 | Jul 1, 2024 |
| EFFECT | — | 9999999995-24-002034 | Jul 1, 2024 | — |
| CORRESP | — | 0001683168-24-004524 | Jun 27, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-004417 | Jun 21, 2024 | Jun 17, 2024 |
| 4 | — | 0001683168-24-004126 | Jun 11, 2024 | Jun 7, 2024 |
| 4 | — | 0001683168-24-004089 | Jun 10, 2024 | Jun 6, 2024 |
| 8-K | CURRENT REPORT | 0001683168-24-003849 | May 28, 2024 | — |
| UPLOAD | — | 0000000000-24-006053 | May 24, 2024 | — |
| RW | FORM RW | 0001683168-24-003696 | May 20, 2024 | — |
| S-3 | FORM S-3 | 0001683168-24-003698 | May 20, 2024 | — |
| 424B5 | PROSPECTUS | 0001683168-24-003600 | May 17, 2024 | — |
| S-1 | S-3 | 0001683168-24-003624 | May 17, 2024 | — |
| 8-K | FORM 8-K | 0001683168-24-003598 | May 17, 2024 | May 16, 2024 |
| 8-K | CURRENT REPORT | 0001683168-24-003178 | May 9, 2024 | — |
| 10-Q | FORM 10-Q FOR 3/31/24 | 0001683168-24-003175 | May 9, 2024 | Mar 31, 2024 |
| ARS | ANNUAL REPORT TO SECURITY HOLDERS | 0001683168-24-003112 | May 8, 2024 | Dec 31, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001683168-24-003113 | May 8, 2024 | Jun 17, 2024 |
| DEFA14A | FORM DEFA14A | 0001683168-24-003114 | May 8, 2024 | — |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001683168-24-002589 | Apr 22, 2024 | Jun 17, 2024 |
| 8-K | CURRENT REPORT | 0001683168-24-002050 | Apr 2, 2024 | — |
| 10-K | 10-K FOR 12/31/23 | 0001683168-24-002021 | Apr 1, 2024 | Dec 31, 2023 |